US EditionOregonians might be eligible for settlement checks from 2 generic drugmakers
- Apotex has agreed to a $39.1 million settlement, and Heritage Pharmaceuticals previously agreed to a $10 million settlement, with a coalition of 50 states and territories, including Michigan, Alaska, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Kansas, Kentucky, Louisiana, Maine, Minnesota, Missouri, Montana, Nebraska, Nevada, New Mexico, New York, North Carolina, North Dakota, Northern Mariana Islands, Oklahoma, Oregon, Rhode Island, South Carolina, Tennessee, U.S. Virgin Islands, Virginia, Washington, West Virginia, and Puerto Rico.
- These settlements resolve allegations that Apotex and Heritage conspired to inflate and manipulate prices for numerous generic prescription drugs, limiting competition and unreasonably restraining trade, impacting consumers nationwide.
- The lawsuits, stemming from a multistate investigation that began in 2016, revealed an "interconnected web of industry executives" engaging in illegal agreements through various social gatherings and communications, as described by officials as one of the largest scandals in U.S. Pharmaceutical history.
- The complaints allege that terms like 'fair share' and 'playing nice in the sandbox' were used to describe how the defendants unlawfully discouraged competition, raised prices, and enforced an ingrained culture of collusion.
- Consumers who purchased certain generic prescription drugs between May 2009 and December 2019 may be eligible for compensation and are urged by attorneys general like Dana Nessel, Aaron Ford, and Dan Rayfield to check their eligibility, ensuring medications remain accessible and sending a message that unethical conduct will not be tolerated.
30 Articles
30 Articles
Indiana part of $39.1M settlement with Apotex over price-fixing in generic drug market
INDIANAPOLIS (WISH) — Indiana Attorney General Todd Rokita urges residents to check their eligibility for compensation as the state joins a $39.1 million settlement with Canadian-based Apotex over allegations of price-fixing and reduced competition in the generic drug market. The settlement, which involves 50 states and territories, seeks preliminary approval in the U.S. District Court for the District of Connecticut. It follows a similar $10 mi…
Dept. of Justice: Attorney General Kaul urges consumers to check eligibility for compensation for inflated generic drug price
MADISON, Wis. – Attorney General Josh Kaul is urging consumers to check their eligibility for compensation for certain generic drug purchases as Wisconsin joins 50 states and territories in seeking preliminary approval for a $39.1 million settlement with generic drug...
Walgreens agrees to pay over $2.8M to settle whistleblower’s claims of inflated prices for meds
Walgreens has agreed to pay over $2.8 million to settle allegations that it inflated prices for certain generic medications and violated federal, Massachusetts and Georgia False Claims Acts, United States Attorney Leah Foley’s office said.The United States, Massachusetts and Georgia claim that Walgreens submitted a higher than usual customary price to the MassHealth and Georgia Medicaid programs for specific generic medications, Foley’s office s…
Coverage Details
Bias Distribution
- 80% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
